Taiwan
· Delayed Price · Currency is TWD UnicoCell Biomed Statistics
Total Valuation
TPE:6794 has a market cap or net worth of TWD 3.95 billion. The enterprise value is 3.46 billion.
| Market Cap | 3.95B |
| Enterprise Value | 3.46B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:6794 has 60.61 million shares outstanding. The number of shares has increased by 6.68% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 60.61M |
| Shares Change (YoY) | +6.68% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 17.84% |
| Owned by Institutions (%) | n/a |
| Float | 21.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 123.77 |
| PB Ratio | 5.76 |
| P/TBV Ratio | 5.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -37.22 |
| EV / Sales | 108.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -51.82 |
Financial Position
The company has a current ratio of 21.83, with a Debt / Equity ratio of 0.10.
| Current Ratio | 21.83 |
| Quick Ratio | 21.11 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.02 |
| Interest Coverage | -70.16 |
Financial Efficiency
Return on equity (ROE) is -14.53% and return on invested capital (ROIC) is -9.04%.
| Return on Equity (ROE) | -14.53% |
| Return on Assets (ROA) | -8.79% |
| Return on Invested Capital (ROIC) | -9.04% |
| Return on Capital Employed (ROCE) | -13.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.32 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 68.50 |
| 200-Day Moving Average | 73.41 |
| Relative Strength Index (RSI) | 41.31 |
| Average Volume (20 Days) | 13,658 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6794 had revenue of TWD 31.88 million and -93.07 million in losses. Loss per share was -1.62.
| Revenue | 31.88M |
| Gross Profit | 20.57M |
| Operating Income | -102.92M |
| Pretax Income | -93.07M |
| Net Income | -93.07M |
| EBITDA | -82.37M |
| EBIT | -102.92M |
| Loss Per Share | -1.62 |
Balance Sheet
The company has 550.24 million in cash and 68.24 million in debt, giving a net cash position of 482.01 million or 7.95 per share.
| Cash & Cash Equivalents | 550.24M |
| Total Debt | 68.24M |
| Net Cash | 482.01M |
| Net Cash Per Share | 7.95 |
| Equity (Book Value) | 684.61M |
| Book Value Per Share | 11.72 |
| Working Capital | 565.22M |
Cash Flow
In the last 12 months, operating cash flow was -61.52 million and capital expenditures -5.32 million, giving a free cash flow of -66.84 million.
| Operating Cash Flow | -61.52M |
| Capital Expenditures | -5.32M |
| Free Cash Flow | -66.84M |
| FCF Per Share | -1.10 |
Margins
Gross margin is 64.52%, with operating and profit margins of -322.83% and -291.94%.
| Gross Margin | 64.52% |
| Operating Margin | -322.83% |
| Pretax Margin | -291.94% |
| Profit Margin | -291.94% |
| EBITDA Margin | -258.35% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPE:6794 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.68% |
| Shareholder Yield | -6.68% |
| Earnings Yield | -2.36% |
| FCF Yield | -1.69% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPE:6794 has an Altman Z-Score of 29.17.
| Altman Z-Score | 29.17 |
| Piotroski F-Score | n/a |